
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
This story was published by BBC. Read the full article on their site.
Read the full story at bbc.com(opens in a new tab)






